Literature DB >> 9736579

Activity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and fungizone against intracellular Candida albicans in murine peritoneal macrophages.

E W van Etten1, W van Vianen, J Hak, I A Bakker-Woudenberg.   

Abstract

Activity against intracellular Candida albicans was assessed in C. albicans-infected murine peritoneal macrophages exposed to long-circulating pegylated amphotericin B liposomes (PEG-AMB-LIP), AmBisome, or Fungizone. The level of antifungal activity of Fungizone is much higher than that of AmBisome or PEG-AMB-LIP, while PEG-AMB-LIP and AmBisome show equivalent activity levels. Previous exposure of uninfected macrophages to PEG-AMB-LIP or AmBisome is advantageous for intracellular antifungal activity.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9736579      PMCID： PMC105849     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Release of amphotericin B from delivery systems and its action against fungal and mammalian cells.

Authors:  P Legrand; M Chéron; L Leroy; J Bolard
Journal:  J Drug Target       Date:  1997       Impact factor: 5.121

2.  Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.

Authors:  J W Van 't Wout; I Meynaar; I Linde; R Poell; H Mattie; R Van Furth
Journal:  J Antimicrob Chemother       Date:  1990-05       Impact factor: 5.790

3.  Sterically stabilized liposomes: physical and biological properties.

Authors:  M C Woodle; M S Newman; J A Cohen
Journal:  J Drug Target       Date:  1994       Impact factor: 5.121

4.  Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans.

Authors:  E W van Etten; H R Chander; S V Snijders; I A Bakker-Woudenberg
Journal:  J Antimicrob Chemother       Date:  1995-12       Impact factor: 5.790

5.  Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.

Authors:  E W van Etten; N E van de Rhee; K M van Kampen; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

6.  Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice.

Authors:  E W van Etten; C van den Heuvel-de Groot; I A Bakker-Woudenberg
Journal:  J Antimicrob Chemother       Date:  1993-11       Impact factor: 5.790

7.  Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.

Authors:  E W van Etten; M T ten Kate; L E Stearne; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

8.  Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue.

Authors:  I A Bakker-Woudenberg; A F Lokerse; M T ten Kate; J W Mouton; M C Woodle; G Storm
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

9.  Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: influence of PEG content and its molecular weight.

Authors:  A Vertut-Doï; H Ishiwata; K Miyajima
Journal:  Biochim Biophys Acta       Date:  1996-01-12

10.  Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size.

Authors:  T M Allen; G A Austin; A Chonn; L Lin; K C Lee
Journal:  Biochim Biophys Acta       Date:  1991-01-09
View more
  2 in total

1.  Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.

Authors:  Qamar Zia; Aijaz Ahmed Khan; Zubair Swaleha; Mohammad Owais
Journal:  Int J Nanomedicine       Date:  2015-03-05

Review 2.  Optimizing efficacy of amphotericin B through nanomodification.

Authors:  Suresh P Vyas; Swati Gupta
Journal:  Int J Nanomedicine       Date:  2006
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.